Диссертация (1174217), страница 33
Текст из файла (страница 33)
Santoro, N. Update in hyper- and hypogonadotropic amenorrhea. / N. Santoro // JClin Endocrinol Metab. – 2011. – Vol. 96. – N. 11. – P. 3281-3288.303. Sarrel, P.M. Hormone replacement therapy in young women with surgical primaryovarian insufficiency. / P.M. Sarrel, S.D. Sullivan, L.M. Nelson // Fertil Steril. –2016. – Vol. 106. – N. 7. – P.
1580-1587.304. Scheid, J.L. Menstrual irregularities and energy deficiency in physically activewomen: the role of ghrelin, PYY and adipocytokines. / J.L. Scheid, M.J. De Souza// Med Sport Sci. – 2010. – Vol. 55. – P. 82-102.305. Schliep, K.C. Perceived stress, reproductive hormones, and ovulatory function: aprospective cohort study. / K.C. Schliep, S.L. Mumford, C.J. Vladutiu, [et al.] //Epidemiology. – 2015. – Vol. 26. – N. 2. – P.
177-184.198306. Schneider, C. Risk of cardiovascular outcomes in users of estradiol/dydrogesteroneor other HRT preparations. / C. Schneider, S.S. Jick, C.R. Meier // Climacteric. –2009. – Vol. 12. – N. 5. – P. 445-453.307. Schneider, H.J. Endocrine dysfunction in patients operated on for non-pituitaryintracranial tumors.
/ H.J. Schneider, S. Rovere, G. Corneli, [et al.] // Eur JEndocrinol. – 2006. – Vol. 155. – N. 4. – P. 559-566.308. Schulz, K.M. The organizing actions of adolescent gonadal steroid hormones onbrain and behavioral development. / K.M. Schulz, C.L. Sisk // Neurosci BiobehavRev. – 2016. – Vol. 70. – P. 148-158.309. Schwarting, G.A. Gonadotropin-releasing hormone neuronal migration. / G.A.Schwarting, M.E.
Wierman, S.A. Tobet // Semin Reprod Med. – 2007. – Vol. 25. –N. 5. – P. 305-312.310. Scott, E. Estrogen neuroprotection and the critical period hypothesis. / E. Scott,Q.G. Zhang, R. Wang, [et al.] // Front Neuroendocrinol. – 2012. – Vol. 33.
– N. 1.– P. 85-104.311. Semple, R.K. The recent genetics of hypogonadotrophic hypogonadism – novelinsights and new questions. / R.K. Semple, A.K. Topaloglu // Clin Endocrinol. –2010. – Vol. 72. – N. 4. – P. 427-435.312. Shadyab, A.H. Ages at menarche and menopause and reproductive lifespan aspredictors of exceptional longevity in women: the Women's Health Initiative. /A.H. Shadyab, С.А. Macera, R.A. Shaffer, [et al.] // Menopause.
– 2017. – Vol. 24.– N. 1. – P. 35-44.313. Shao, S. Clinical features and analysis in 1385 Chinese patients with pituitaryadenomas. / S. Shao, X. Li. // J Neurosurg Sci. – 2013. – Vol. 57. – N. 3. –P. 267-275.314. Sheehan, J.P. Gamma Knife radiosurgery for the management of nonfunctioningpituitary adenomas: a multicenter study. / J.P. Sheehan, R.M. Starke, D. Mathieu,[et al.] // J Neurosurg.
– 2013. – Vol. 119. – N. 2. – P. 446-456.315. Sherlock, M. Mortality in patients with pituitary disease. / M. Sherlock, J. Ayuk,J.W. Tomlinson, [et al.] // Endocr Rev. – 2010. – Vol. 31. – N. 3. – P. 301-42199316. Shifren,J.L.Androgens inpostmenopausalwomen:areview./J.L.Shifren, S.R.Davis. // Menopause. – 2017. – Vol.
24. – N. 8. – P. 970-979.317. Shufelt, C.L. Hormone therapy dose, formulation, route of delivery, and risk ofcardiovascular events in women: findings from the Women's Health InitiativeObservational Study. / C.L. Shufelt, C.N. Merz, R.L. Prentice [et al.] // Menopause.– 2014. – Vol. 21. – N.
3. – P. 260-266.318. Shuster, L.T. Premature menopause or early menopause: long-term healthconsequences. / L.T. Shuster, D.J. Rhodes, B.S. Gostout, [et al.] // Maturitas. – 2010– Vol. 65. – N.2. – P. 161-166.319. Siddiqui, A.N. Neuroprotective Role of Steroidal Sex Hormones: An Overview. /A.N. Siddiqui, N. Siddiqui, R.A. Khan, [et al.] // CNS Neurosci Ther. – 2016. – Vol.22. – N. 5. – P. 342-350.320.
Simon, J.A. Venous thromboembolism and cardiovascular disease complications inmenopausal women using transdermal versus oral estrogen therapy. / J.A. Simon,F. Laliberté, M.S. Duh // Menopause. – 2016. – Vol. 23. – N. 6. – P. 600-610.321. Soni, M. Premature ovarian insufficiency and neurological function. / M. Soni, E.Hogervorst // Minerva Endocrinol.
– 2014. – Vol. 39. – N. 3. – P. 189-199.322. Soules, M.R. Executive summary: Stages of Reproductive Aging Workshop(STRAW). / M.R. Soules, S. Sherman, E. Parrott, [et al.] // Climacteric. – 2001. –N 4. – P. 267-272.323. Sowińska-Przepiera, E. Bone mineral density in girls with functional hypothalamicamenorrhea subjected to estroprogestagen treatment – a 4-year prospective study. /E. Sowińska-Przepiera, K. Chełstowski, Z. Friebe, A. Syrenicz // GynecolEndocrinol. – 2011. – Vol. 27.
– N. 11. – P. 966-970.324. Stanczyk, F.Z. Progestogens used in postmenopausal hormone therapy: differencesin their pharmacological properties, intracellular actions, and clinical effects. / F.Z.Stanczyk, J.P. Hapgood, S. Winer, D.R. Mishell Jr // Endocr Rev. – 2013. – Vol. 34.– N. 2. – P. 171-208.325. Stevenson, J.C. Oral estradiol and dydrogesterone combination therapy inpostmenopausal women: review of efficacy and safety. / J.C. Stevenson, N.
Panay,C. Pexman-Fieth // Maturitas. – 2013. – Vol. 76. – N.1. – P. 10-21.200326. Sullivan, S.D. Hormone replacement therapy in young women with primary ovarianinsufficiency and early menopause. / S.D. Sullivan, P.M. Sarrel, L.M. Nelson //Fertil Steril. – 2016. – Vol. 106.
– N. 7. – P. 1588-1599.327. Svejme, O. Early menopause and risk of osteoporosis, fracture and mortality: a 34year prospective observational study in 390 women. / O. Svejme, H.G. Ahlborg,J.Å. Nilsson, M.K. Karlsson // BJOG. – 2012. – Vol. 119. – N 7. – P. 810-816., 69328. Szczepanowska, K. Different faces of mitochondrial DNA mutators. / K.Szczepanowska, A. Trifunovic // Biochim Biophys Acta. – 2015. – Vol. 1847. –N. 11. – P.
1362-1372.329. Tanmahasamut, P. Causes of primary amenorrhea: a report of 295 cases in Thailand./ P. Tanmahasamut, M. Rattanachaiyanont, C. Dangrat, [et al.] // J Obstet GynaecolRes. –2012. – Vol. 38. – N. 1. – P. 297-301.330. Taku, N. Time Dependence of Radiation-induced Hypothalamic-Pituitary AxisDysfunction in Adults Treated for Non-pituitary, Intracranial Neoplasms.
/ N. Taku,M. Gurnell, N. Burnet, R. Jena // Clin Oncol (R Coll Radiol). – 2017. – Vol. 29. –N. 1. – P. 34-41.331. Tanriverdi, F. Neuroendocrine Disturbances after Brain Damage: An Important andOften Undiagnosed Disorder. / F. Tanriverdi, F. Kelestimur // J Clin Med. – 2015.– Vol. 4. – N.
5. – P. 847-857.332. Taylor, H.S. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Functionin Early Postmenopause: Ancillary Study of the Kronos Early Estrogen PreventionStudy (KEEPS). / H.S. Taylor, A. Tal, L. Pal, [et al.] // JAMA Intern Med. – 2017.– Vol. 177.
– N. 10. – P. 1471-1479.333. Tena-Sempere, M. Interaction between energy homeostasis and reproduction:central effects of leptin and ghrelin on the reproductive axis. / M. Tena-Sempere //Horm Metab Res. – 2013. – Vol. 45. – N. 13. – P. 919-927.334. Thompson, I.R.
GnRH pulse frequency-dependent differential regulation of LH andFSH gene expression. / I.R. Thompson, U.B. Kaiser // Mol Cell Endocrinol. – 2014.– Vol. 385. – N. (1-2). – P. 28-35.201335. Thurston, R. Vasomotor symptoms and menopause: findings from the Study ofWomen’s Health Across the Nation. / R. Thurston, H. Joffe // Obstet Gynecol ClinNorth Am. – 2011.
– Vol. 38. – P. 489-501.336. Thurston, R.C. Are vasomotor symptoms associated with alterations in hemostaticand inflammatory markers? Findings from the Study of Women’s Health Across theNation. / R.C. Thurston, S.R. Khoudary, K. Sutton-Tyrrell, [et al.] // Menopause. –2011. – Vol.
15. – P. 1044-1051.337. Thurston, R.C. History of hot flashes and aortic calcification amongpostmenopausal women. / R.C. Thurston, L.H. Kuller, D. Edmundowicz, K.A.Matthews // Menopause. – 2010. – Vol. 17. – P. 256-261.338. Thurston, R.C. Hot flashes and cardiac vagal control: a link to cardiovascular risk?/ R.C. Thurston, I.C. Christie, K.A. Matthews // Menopause.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
